Overview
ASBP market data
Price History
ASBP price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$16.38 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.21 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $3.31 – $1,050.00 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $6.8.
Company news
Aspire Biopharma to Present at the Life Sciences Investor Forum on June 25thGlobenewswire Inc · Jun 17, 2026, 3:15 PM
Aspire Biopharma Stock Is Sliding Today: What's Going On?Benzinga · Jun 12, 2026, 2:15 PM
Aspire Biopharma Strikes Agreement To Acquire Dura Driver Control Systems For $30M In CashBenzinga · Jun 12, 2026, 12:35 PM
Aspire Biopharma Hldgs Q1 EPS $(20.57) Up From $(504.88) YoY, Sales $28.353KBenzinga · May 15, 2026, 10:47 PM